pierce this barrier to successful immunotherapy. Finally, success in the case of infectious disease has a prophylactic setting, whereas the challenge of cancer lies in the domain of treating pre ...

“Because we have the potential to turn non-immunogenic components into strong immunogens, we are in a position to leverage the full potential of immunotherapy, including prophylactic applications.

Harnessing the immune system to treat chronic infectious diseases or cancer is a major goal of immunotherapy. Among others, impediments to this aim include host failure to identify tumor antigens ...

Many of the different antigens used in immunotherapy have very low affinities for their MHC molecules. Therefore, immunotherapies have been enhanced by the modification of the antigenic peptide by ...

Prophylactic measures are crucial to reduce infection-related morbidity and mortality in MM patients, especially before immunotherapy becomes widespread. The study provides a baseline for ...

"Immunotherapy has been very hot recently ... A pentavalent peptide vaccine elicits Aβ and tau antibodies with prophylactic ...

“We aim to develop BioNTech into a global immunotherapy powerhouse with the potential to improve the standard of care with innovative oncology products and prophylactic vaccines against ...